Rehabilitation exercise assessment using inertial sensors: a cross-sectional analytical study

por Giggins, Oonagh M, Sweeney, Kevin T, Caulfield, Brian
Publicado en J Neuroeng Rehabil (2014)

Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin(®)) in patients with advanced non-squamous non-small cell lung canc...

por Li, Cheryl S. W., Sweeney, Kevin, Cronenberger, Carol
Publicado en Cancer Chemother Pharmacol (2019)

An Ambulatory Method of Identifying Anterior Cruciate Ligament Reconstructed Gait Patterns

por Patterson, Matthew R., Delahunt, Eamonn, Sweeney, Kevin T., Caulfield, Brian
Publicado 2014

Does the Systemic Plasma Profile Inform the Liver Profile? Analysis Using a Physiologically Based Pharmacokinetic Model and Individual Compounds

por Li, Rui, Maurer, Tristan S., Sweeney, Kevin, Barton, Hugh A.
Publicado en AAPS J (2016)

Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin With Different Dosing Regimens Used in COVID‐19 Clinical Trials

por Hughes, Jim H., Sweeney, Kevin, Ahadieh, Sima, Ouellet, Daniele
Publicado en CPT Pharmacometrics Syst Pharmacol (2020)

Population Pharmacokinetic Analysis of Dalteparin in Pediatric Patients With Venous Thromboembolism

por Damle, Bharat, Jen, Frank, Sherman, Nancy, Jani, Darshana, Sweeney, Kevin
Publicado en J Clin Pharmacol (2020)

Penetration of Fleroxacin and Ciprofloxacin into Skin Blister Fluid: a Comparative Study

por Lubowski, Teresa J., Nightingale, Charles, Sweeney, Kevin, Zhi, Jianguo, Quintiliani, Richard
Publicado 1993

Population pharmacokinetics and exposure–response analyses of varenicline in adolescent smokers

por Fediuk, Daryl J., Sweeney, Kevin, Sahasrabudhe, Vaishali, McRae, Thomas, Byon, Wonkyung
Publicado en CPT Pharmacometrics Syst Pharmacol (2021)

Exposure to household pet cats and dogs in childhood and risk of subsequent diagnosis of schizophrenia or bipolar disorder

por Yolken, Robert, Stallings, Cassie, Origoni, Andrea, Katsafanas, Emily, Sweeney, Kevin, Squire, Amalia, Dickerson, Faith
Publicado en PLoS One (2019)

Individuals Hospitalized with Acute Mania Have Increased Exposure to Antimicrobial Medications

por Yolken, Robert, Adamos, Maria, Katsafanas, Emily, Khushalani, Sunil, Origoni, Andrea, Savage, Christina, Schweinfurth, Lucy, Stallings, Cassie, Sweeney, Kevin, Dickerson, Faith
Publicado en Bipolar Disord (2016)

Atypical Immune Response to Epstein-Barr Virus in Major Depressive Disorder

por Jones-Brando, Lorraine, Dickerson, Faith, Ford, Glen, Stallings, Cassie, Origoni, Andrea, Katsafanas, Emily, Sweeney, Kevin, Squire, Amalia, Khushalani, Sunil, Yolken, Robert
Publicado en J Affect Disord (2019)

End‐to‐end application of model‐informed drug development for ertugliflozin, a novel sodium‐glucose cotransporter 2 inhibitor

por Fediuk, Daryl J., Nucci, Gianluca, Dawra, Vikas K., Callegari, Ernesto, Zhou, Susan, Musante, Cynthia J., Liang, Yali, Sweeney, Kevin, Sahasrabudhe, Vaishali
Publicado en CPT Pharmacometrics Syst Pharmacol (2021)

Schizophrenia is Associated With an Aberrant Immune Response to Epstein–Barr Virus

por Dickerson, Faith, Jones-Brando, Lorraine, Ford, Glen, Genovese, Giulio, Stallings, Cassie, Origoni, Andrea, O’Dushlaine, Colm, Katsafanas, Emily, Sweeney, Kevin, Khushalani, Sunil, Yolken, Robert
Publicado en Schizophr Bull (2019)

The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism

por Eudy, Rena J, Sahasrabudhe, Vaishali, Sweeney, Kevin, Tugnait, Meera, King-Ahmad, Amanda, Near, Kristen, Loria, Paula, Banker, Mary Ellen, Piotrowski, David W, Boustany-Kari, Carine M
Publicado 2011

Study protocol: The registrar clinical encounters in training (ReCEnT) study

por Morgan, Simon, Magin, Parker J, Henderson, Kim M, Goode, Susan M, Scott, John, Bowe, Steven J, Regan, Catherine M, Sweeney, Kevin P, Jackel, Julian, van Driel, Mieke L
Publicado 2012

Spatial repellents: from discovery and development to evidence-based validation

por Achee, Nicole L, Bangs, Michael J, Farlow, Robert, Killeen, Gerry F, Lindsay, Steve, Logan, James G, Moore, Sarah J, Rowland, Mark, Sweeney, Kevin, Torr, Steve J, Zwiebel, Laurence J, Grieco, John P
Publicado 2012

Probiotic normalization of Candida albicans in schizophrenia: a randomized, placebo-controlled, longitudinal pilot study

por Severance, Emily G., Gressitt, Kristin L., Stallings, Cassie R., Katsafanas, Emily, Schweinfurth, Lucy A., Savage, Christina L. G., Adamos, Maria B., Sweeney, Kevin M., Origoni, Andrea E., Khushalani, Sunil, Dickerson, Faith B., Yolken, Robert H.
Publicado en Brain Behav Immun (2016)

Exposure to Epstein Barr Virus and Cognitive Functioning in Individuals with Schizophrenia

por Dickerson, Faith, Katsafanas, Emily, Origoni, Andrea, Squire, Amalia, Khushalani, Sunil, Newman, Theresa, Rowe, Kelly, Stallings, Cassie, Savage, Christina L.G., Sweeney, Kevin, Nguyen, Tanya T., Breier, Alan, Goff, Donald, Ford, Glen, Jones-Brando, Lorraine, Yolken, Robert
Publicado en Schizophr Res (2021)

Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder

por Severance, Emily G, Gressitt, Kristin L, Stallings, Catherine R, Katsafanas, Emily, Schweinfurth, Lucy A, Savage, Christina L, Adamos, Maria B, Sweeney, Kevin M, Origoni, Andrea E, Khushalani, Sunil, Leweke, F Markus, Dickerson, Faith B, Yolken, Robert H
Publicado en NPJ Schizophr (2016)